Reddys Laboratories launches generic version of fesoterodine fumarate tablets in US
The company's fesoterodine fumarate extended-release tablets are available in 4 mg and 8 mg tablets, each in bottle count sizes of 30. These are the therapeutic generic equivalent of Toviaz Dr Reddy's said the Toviaz brand had US sales of approximately USD 211 million for the most recent 12 months ended May 2022
Dr Reddys Said it has launched its generic version of fesoterodine fumarate extended-release tablets used for treating overactive bladder in the US market. The launch follows the approval granted by the US Food and Drug Administration (USFDA), the pharma company said in a regulatory filing. The company's fesoterodine fumarate extended-release tablets are available in 4 mg and 8 mg tablets, each in bottle count sizes of 30. These are the therapeutic generic equivalent of Toviaz, it added. Citing IQVIA data, Dr Reddy's said the Toviaz brand had US sales of approximately USD 211 million for the most recent 12 months ended May 2022
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!